Home › Funds › Kepler Cheuvreux (Suisse) SA › RPRX

Kepler Cheuvreux (Suisse) SA position in RPRX

ROYALTY PHARMA PLC · Health Care

Kepler Cheuvreux (Suisse) SA reported holding 391,457 shares of RPRX (ROYALTY PHARMA PLC) in its Q3 2026 13F filing — a position valued at US$22.8M, representing 1.39% of its reported portfolio and ranking #25 among its reported holdings. Kepler Cheuvreux (Suisse) SA has disclosed RPRX holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)391.46K sh
Reported value held$22.85M
Portfolio Weight1.39%
First reportedQ2 2026
Last changeAdd
Updated2026-10-20

Last updated: 2026-10-20 · Source: SEC EDGAR Form 13F-HR

How Kepler Cheuvreux (Suisse) SA's RPRX position evolved

Kepler Cheuvreux (Suisse) SA first disclosed a stake in RPRX in Q2 2026 at 160,345 shares (US$9.0M). The position peaked in Q3 2026 at 391,457 shares, worth US$22.8M. Across 2 filings, Kepler Cheuvreux (Suisse) SA increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 391,457 shares valued at US$22.8M — an increase of 231,112 shares quarter over quarter.. Notable position changes include a 144% increase in Q3 2026 (shares rose 15% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2026 160.34K $8.99M New
Q3 2026 391.46K $22.85M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RPRX and 13F data

RPRX (ROYALTY PHARMA PLC) is a Health Care company. 50 other funds we track also report a position in RPRX — the largest reported positions include Swedbank AB (US$601.4M), Baillie Gifford & Co (US$561.6M), Caledonia (Private) Investments Pty Ltd (US$323.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RPRX

All RPRX fund holders →

FAQ

How long has Kepler Cheuvreux (Suisse) SA held RPRX?

Kepler Cheuvreux (Suisse) SA has disclosed RPRX holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is Kepler Cheuvreux (Suisse) SA's current position in RPRX?

As of Q3 2026, Kepler Cheuvreux (Suisse) SA holds 391.46K shares of RPRX (ROYALTY PHARMA PLC), valued at $22.85M, representing 1.39% of its reported portfolio and ranking #25.

Has Kepler Cheuvreux (Suisse) SA been buying or selling RPRX?

In the latest 13F filing (Q3 2026), Kepler Cheuvreux (Suisse) SA increased its position in RPRX. The position peaked in Q3 2026 at 391.46K shares.

Which other funds hold RPRX?

Other major institutional holders of RPRX include Swedbank AB, Baillie Gifford & Co, Caledonia (Private) Investments Pty Ltd, among 50 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.